Elizabeth Czerepak - Net Worth and Insider Trading

Elizabeth Czerepak Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Elizabeth Czerepak owns 8 companies in total, including Spectrum Pharmaceuticals Inc (SPPI) , Delcath Systems Inc (DCTH) , and Altimmune Inc (ALT) among others .

Click here to see the complete history of Elizabeth Czerepak’s form 4 insider trades.

Insider Ownership Summary of Elizabeth Czerepak

Ticker	Comapny	Transaction Date	Type of Owner
SPPI	Spectrum Pharmaceuticals Inc	2019-06-19	director
DCTH	Delcath Systems Inc	2020-11-23	director
ALT	Altimmune Inc	2017-05-04	See Remarks
		2013-04-04	Chief Financial Officer
		2007-05-31	director & 10 percent owner
		2021-11-15	director
		2013-04-04	Chief Financial Officer
		2022-11-10	See Remarks

Elizabeth Czerepak Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Elizabeth Czerepak Ownership Network

Ownership Network List of Elizabeth Czerepak

No Data

Ownership Network Relation of Elizabeth Czerepak

Elizabeth Czerepak Owned Company Details

What does Spectrum Pharmaceuticals Inc do?

Who are the key executives at Spectrum Pharmaceuticals Inc?

Elizabeth Czerepak is the director of Spectrum Pharmaceuticals Inc. Other key executives at Spectrum Pharmaceuticals Inc include See Remarks Nora Brennan , Chief Legal Officer Keith M Mcgahan , and director & CEO & President Thomas J Riga .

Spectrum Pharmaceuticals Inc (SPPI) Insider Trades Summary

Over the past 18 months, Elizabeth Czerepak made no insider transaction in Spectrum Pharmaceuticals Inc (SPPI). Other recent insider transactions involving Spectrum Pharmaceuticals Inc (SPPI) include a net sale of 32,387 shares made by Nora Brennan ,

In summary, during the past 3 months, insiders sold 0 shares of Spectrum Pharmaceuticals Inc (SPPI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 32,387 shares of Spectrum Pharmaceuticals Inc (SPPI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 32,387 shares.

Spectrum Pharmaceuticals Inc (SPPI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Spectrum Pharmaceuticals Inc Insider Transactions

No Available Data

What does Delcath Systems Inc do?

Who are the key executives at Delcath Systems Inc?

Elizabeth Czerepak is the director of Delcath Systems Inc. Other key executives at Delcath Systems Inc include See Remarks Vojo Vukovic , director & Chief Executive Officer Gerard J Michel , and See Remarks Sandra Pennell .

Delcath Systems Inc (DCTH) Insider Trades Summary

Over the past 18 months, Elizabeth Czerepak made no insider transaction in Delcath Systems Inc (DCTH). Other recent insider transactions involving Delcath Systems Inc (DCTH) include a net purchase of 100,000 shares made by Vojo Vukovic , a net purchase of 40,000 shares made by David L. Hoffman , and a net purchase of 34,000 shares made by Gerard J Michel .

In summary, during the past 3 months, insiders sold 0 shares of Delcath Systems Inc (DCTH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Delcath Systems Inc (DCTH) were sold and 282,819 shares were bought by its insiders, resulting in a net purchase of 282,819 shares.

Delcath Systems Inc (DCTH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Delcath Systems Inc Insider Transactions

No Available Data

What does Altimmune Inc do?

Who are the key executives at Altimmune Inc?

Elizabeth Czerepak is the See Remarks of Altimmune Inc. Other key executives at Altimmune Inc include Chief Financial Officer Richard I Eisenstadt , Chief Medical Officer Matthew Scott Harris , and Chief Business Officer Raymond M Jordt .

Altimmune Inc (ALT) Insider Trades Summary

Over the past 18 months, Elizabeth Czerepak made no insider transaction in Altimmune Inc (ALT). Other recent insider transactions involving Altimmune Inc (ALT) include a net sale of 15,711 shares made by David Drutz ,

In summary, during the past 3 months, insiders sold 16,011 shares of Altimmune Inc (ALT) in total and bought 0 shares, with a net sale of 16,011 shares. During the past 18 months, 16,011 shares of Altimmune Inc (ALT) were sold and 300 shares were bought by its insiders, resulting in a net sale of 15,711 shares.

Altimmune Inc (ALT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Altimmune Inc Insider Transactions

No Available Data

What does Cancer Genetics Inc do?

Who are the key executives at Cancer Genetics Inc?

Elizabeth Czerepak is the Chief Financial Officer of Cancer Genetics Inc. Other key executives at Cancer Genetics Inc include President & Discovery Services Ralf Brandt , Chief Financial Officer Michael Glenn Miles , and Chief Executive Officer John A Roberts .

Cancer Genetics Inc (CGIX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cancer Genetics Inc (CGIX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cancer Genetics Inc (CGIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cancer Genetics Inc (CGIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cancer Genetics Inc Insider Transactions

No Available Data

What does Affymax Inc do?

Who are the key executives at Affymax Inc?

Elizabeth Czerepak is the director & 10 percent owner of Affymax Inc. Other key executives at Affymax Inc include Chief Financial Officer Mark G Thompson , Chief Commercial Officer Jeffrey H Knapp , and Chief Financial Officer Herb Cross .

Affymax Inc (AFFY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Affymax Inc (AFFY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Affymax Inc (AFFY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Affymax Inc (AFFY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Affymax Inc Insider Transactions

No Available Data

What does Sorrento Therapeutics Inc do?

Who are the key executives at Sorrento Therapeutics Inc?

Elizabeth Czerepak is the director of Sorrento Therapeutics Inc. Other key executives at Sorrento Therapeutics Inc include director & See Remarks Henry Ji , Chief Financial Officer Najjam Asghar , and See Remarks Jerome B Zeldis .

Sorrento Therapeutics Inc (SRNE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sorrento Therapeutics Inc (SRNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sorrento Therapeutics Inc (SRNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sorrento Therapeutics Inc (SRNE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sorrento Therapeutics Inc Insider Transactions

No Available Data

What does Vyant Bio Inc do?

Who are the key executives at Vyant Bio Inc?

Elizabeth Czerepak is the Chief Financial Officer of Vyant Bio Inc. Other key executives at Vyant Bio Inc include Chief Executive Officer John A Roberts , Chief Financial Officer Lafrence Andrew D.c. , and director & Chief Innovation Officer Yung-ping Yeh .

Vyant Bio Inc (VYNT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Vyant Bio Inc (VYNT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vyant Bio Inc (VYNT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Vyant Bio Inc (VYNT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vyant Bio Inc Insider Transactions

No Available Data

What does Scilex Holding Co do?

Who are the key executives at Scilex Holding Co?

Elizabeth Czerepak is the See Remarks of Scilex Holding Co. Other key executives at Scilex Holding Co include director & Executive Chairperson Henry Ji , director & See Remarks Jaisim Shah , and Chief Financial Officer Stephen Hoi Ma .

Scilex Holding Co (SCLX) Insider Trades Summary

Over the past 18 months, Elizabeth Czerepak made no insider transaction in Scilex Holding Co (SCLX). Other recent insider transactions involving Scilex Holding Co (SCLX) include a net purchase of 202,000 shares made by Jaisim Shah , a net purchase of 68,888 shares made by Henry Ji , and a net purchase of 62,500 shares made by Jay Chun .

In summary, during the past 3 months, insiders sold 0 shares of Scilex Holding Co (SCLX) in total and bought 115,588 shares, with a net purchase of 115,588 shares. During the past 18 months, 0 shares of Scilex Holding Co (SCLX) were sold and 377,228 shares were bought by its insiders, resulting in a net purchase of 377,228 shares.

Scilex Holding Co (SCLX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Scilex Holding Co Insider Transactions

No Available Data

Elizabeth Czerepak Mailing Address

Above is the net worth, insider trading, and ownership report for Elizabeth Czerepak. You might contact Elizabeth Czerepak via mailing address: 201 Route 17 North, Rutherford Nj 07070.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.